The association between vitamin D deficiency and the risk of resistant hypertension

References

• Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48–54. doi:10.1016/j.nutres.2010.12.001. PMID:21310306.
   PubMed Web of Science ®Google Scholar
• Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169(6):626–32. doi:10.1001/archinternmed.2008.604. PMID:19307527.
   PubMedGoogle Scholar
• Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm HP, Dobnig H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross sectional study of patients referred for coronary angiography. J Clin Endocrinol Metabol. 2008;93(10):3927–35. doi:10.1210/jc.2008-0784. PMID:18682515.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174–80. doi:10.1001/archinte.168.11.1174. PMID:18541285.
   PubMedGoogle Scholar
• Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005;16(2):83–95. doi:10.07/s10552-004-1661-4. PMID:15262450.
   PubMed Web of Science ®Google Scholar
• Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13(9):1502–08. PMID:15342452.
   PubMed Web of Science ®Google Scholar
• Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629–37. doi:10.1001/archinte.168.15.1629. PMID:18695076.
   PubMed Web of Science ®Google Scholar
• Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens. 2011;29(4):636–45. doi:10.1097/HJH.0b013e32834320f9. PMID:21191311.
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, et al. Resistant hypertension: diagnosis, evaluation and treatment. A scientific statement from the American heart association professional education committee of the council for high blood pressure research. Hypertension. 2008;51(6):1403–19. doi:10.1161/HYPERTENSIONAHA.108.189141. PMID:18931085.
   PubMed Web of Science ®Google Scholar
• Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O‘Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635–42. doi:10.1161/CIRCULATIONAHA.111.068064. PMID:22379110.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, Severgnini B, Meani S, Magrini F, Zanchetti A. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens. 2001;19(11):2063–70. PMID:11677373.
   PubMed Web of Science ®Google Scholar
• Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011;57(6):1076–80. doi:10.1161/HYPERTENSIONAHA.111.170308. PMID:21502568.
   PubMed Web of Science ®Google Scholar
• de la Sierra A, Banegas JR, Oliveras A, Gorostidi M, Segura J, de la Cruz JJ, Armario P, Ruilope LM. Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens. 2012;30(6):1211–16. doi:10.1097/HJH.0b013e328353634e. PMID:22525201.
   PubMed Web of Science ®Google Scholar
• Belen E, Şahin İ, Güngör B, Ayça B, Avcı İİ, Avşar M, Yıldız SS, Akın F, Bozbeyoglu E, Okuyan E. Assessment of 25-hydroxyvitamin D levels in patients with resistant hypertension. Med Princ Pract. 2016;25(1):25–30. doi:10.1159/000437227. PMID:26278895.
   PubMed Web of Science ®Google Scholar
• Witham MD, Ireland S, Houston JG, Gandy SJ, Waugh S, Macdonald TM, Mackenzie IS, Struthers AD. Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension. 2014;63(4):706–12. doi:10.1161/HYPERTENSIONAHA.113.02177. PMID:24420547.
   PubMed Web of Science ®Google Scholar
• Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the third national health and nutrition examination survey. Am J Hypertens. 2007;20(7):713–19. doi:10.1016/j.amjhyper.2007.01.017. PMID:17586404.
   PubMed Web of Science ®Google Scholar
• Pöss J, Mahfoud F, Ukena C, Esler MD, Schlaich M, Hering D, Cremers B, Laufs U, Böhm M. Association of vitamin D status and blood pressure response after renal denervation. Clin Res Cardiol. 2014;103(1):41–47. doi:10.1007/s00392-013-0621-y. PMID:24173883.
   PubMed Web of Science ®Google Scholar
• Arora P, Song Y, Dusek J, Plotnikoff G, Sabatine MS, Cheng S, Valcour A, Swales H, Taylor B, Carney E, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 2015;131(3):254–62. doi:10.1161/CIRCULATIONAHA.114.011732. PMID:25359163.
   PubMed Web of Science ®Google Scholar
• Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, Treiber G, Drechsler C, Ó Hartaigh B, Obermayer-Pietsch B, et al. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension. 2015;65(6):1195–201. doi:10.1161/HYPERTENSIONAHA.115.05319. PMID:25801871.
   PubMed Web of Science ®Google Scholar
• Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, Bennett GG, Chandler PD, Hollis BW, Emmons KM, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013;61(4):779–85. doi:10.1161/HYPERTENSIONAHA.111.00659. PMID:23487599.
   PubMed Web of Science ®Google Scholar
• Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009;27(10):1948–54. doi:10.1097/HJH.0b013e32832f075b. PMID:19587609.
   PubMed Web of Science ®Google Scholar
• Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010;55(5):1283–88. doi:10.1161/HYPERTENSIONAHA.109.148619. PMID:20351344.
   PubMed Web of Science ®Google Scholar
• Sowers JR, Whaley-Connell A, Epstein M. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med. 2009;150(11):776–83. PMID:19487712.
   PubMed Web of Science ®Google Scholar
• Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87. doi:10.2147/JIR.S63898. PMID:24971027.
   PubMedGoogle Scholar
• Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25(3):320–25. doi:10.1111/j.1464-5491.2007.02360. PMID:18279409.
   PubMed Web of Science ®Google Scholar